\"

Pre Conference Workshop Day

10:00 AM - 12:00 PM Quality Assurance and Regulatory Aspect of Cell and Gene Therapy Bioprocesses

  • Identify which QbD is the right approach for your therapy and examine its effectiveness when moving into the manufacturing stage
  • Decipher the different regulatory guidelines surrounding ATMP production
  • Address the different regulatory guidelines that are associated with ATMP manufacturing processes

12:00 PM - 1:00 PM Lunch

1:00 PM - 3:00 PM Commercialisation of Cell and Gene Therapies

  • Analyse the different approaches towards commercialisation of cell and gene therapies
  • Look after the different factors associated with development of therapies after stage 3 of clinical development
  • Examine datasets from autologous therapies, how to make products more viable and cost efficiency of large scale production